Like previously detected variants also the mutations of the Omicron variant are affecting the spike protein of SARS-CoV-2, which explains why the variants are making the virus more infectious.

​

AMP Rapid Test SARS-CoV-2 Ag detects the presence of the nucleocapsid protein antigen and thus the performance of the test is not affected by the mutations.

​

Clinical evaluations of samples proven to include the Omicron variant evidenced, that the reliability of test results remains unaffected.